Pharma Focus Asia

Syngene Introduces Innovative Platform for Quick and Enhanced Protein Production

Wednesday, June 05, 2024

Syngene International Ltd. (NSE: SYNGENE) has recently introduced its latest protein production platform, integrating cell line and transposon-based technology from ExcellGene, a Swiss biotech services company, with its own clone selection and development processes. This novel approach promises significant advancements in efficiency and precision in protein production.

This new platform aims to expedite preclinical and clinical development cycles and accelerate product launches, ultimately reducing time to market for clients. Sridevi Khambhampaty, Vice President of Biopharmaceutical Development at Syngene International, highlighted the benefits of combining ExcellGene's technology with Syngene's processes, emphasizing its potential to enhance reliability and efficiency.

Syngene International, emphasized the company's commitment to leveraging cutting-edge technology to ensure speed and precision for clients, particularly in the biologics sector. Maria J. and Florian M. Wurm, Cofounders and Managers of ExcellGene, expressed their excitement about the partnership with Syngene and its potential to benefit a wide range of clients.

The new platform not only improves clone selection and operational productivity but also accommodates various biomolecules, facilitating integration with different manufacturing processes. Its effectiveness is demonstrated by its successful track record in developing multiple monoclonal antibodies, showcasing Syngene's capability to provide innovative solutions to its clients.

With this advancement, Syngene now offers a comprehensive range of cell line development options, utilizing state-of-the-art technology to deliver tangible benefits to customers.



Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024